Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
US5134155A · kind A · utility
16Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 1991 |
| Grant date | Jul 28, 1992 |
| Priority date | — |
| Expiry date | Aug 8, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D231/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the general formula I: ##STR1## are disclosed as useful in the treatment or prevention of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis. Novel intermediate compounds used to make the compound of formula I are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.